Governors Lane LP Global Blood Therapeutics, Inc. Transaction History

Governors Lane LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $5.45 Million - $9.24 Million	-144,861 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $4.31 Million - $6.08 Million	81,661 Added 129.21%	144,861 $7.99 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $3.08 Million - $5.17 Million	63,200 New	63,200 $3.99 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

Stay updated on Governors Lane LP with notifications on news.